Strain Report - Rat Genome Database
Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Strain: OLETF.BN-(D1Rat76-D1Rat459)/Got

Symbol: OLETF.BN-(D1Rat76-D1Rat459)/Got
Strain: OLETF.BN-(D1Rat76-D1Rat459)
Substrain: Got
RGD ID: 734528
RRID: RGD_734528
Ontology ID: RS:0000622
Also known as: OLETF.BN-(D1Rat76-D1Rat459)/Got
Type: congenic
Source: Otsuka Pharmacuetical Company, 463-10 Kagasuno, Tokushima, Japan
Origin: Female OLETF/Got rats were crossed with male BN rats. The F1 were backcrossed to OLETF to produce the BC1. Selective males from BC1 were backcrossed to OLETF to produce successive congenic generations.
Last Known Status: Unknown
Rat AssemblyChrPosition (strand)SourceJBrowse
Rnor_6.01244,992,467 - 282,365,384RGD_MAPPER_PIPELINERnor6.0
Rnor_5.01252,243,728 - 289,700,417RGD_MAPPER_PIPELINERnor5.0
RGSC_v3.41230,411,091 - 267,593,558RGD_MAPPER_PIPELINERGSC3.4


References - curated
1. RGD Automated Pipelines
2. Watanabe TK, etal., Clin Exp Pharmacol Physiol 2001 Jan-Feb;28(1-2):28-42.


Position Markers

Flank 1 / 1 (D1Rat76)
Rat AssemblyChrPosition (strand)Source
Rnor_6.01244,992,467 - 244,992,610NCBI
Rnor_5.01252,243,728 - 252,243,871UniSTS
RGSC_v3.41230,411,091 - 230,411,453RGD
RGSC_v3.41230,411,111 - 230,411,254UniSTS
RGSC_v3.11230,575,134 - 230,575,277RGD
Celera1221,760,461 - 221,760,604UniSTS
RH 3.4 Map11612.0RGD
RH 3.4 Map11612.0UniSTS
SHRSP x BN Map1125.42UniSTS
SHRSP x BN Map1125.42RGD
FHH x ACI Map1111.18RGD

Flank 2 / 1 (D1Rat459)
Rat AssemblyChrPosition (strand)Source
Rnor_6.01282,365,175 - 282,365,384NCBI
Rnor_5.01289,700,208 - 289,700,417UniSTS
RGSC_v3.41267,593,349 - 267,593,558UniSTS
RGSC_v3.41267,593,348 - 267,593,558RGD
RGSC_v3.11267,804,434 - 267,804,643RGD
Celera1255,762,929 - 255,763,138UniSTS
Cytogenetic Map1q55UniSTS
RH 3.4 Map11704.5UniSTS
RH 3.4 Map11704.5RGD
RH 2.0 Map11311.7999RGD
SHRSP x BN Map1148.19RGD
Strain QTL Data
Symbol Name Trait
Niddm58 Non-insulin dependent diabetes mellitus QTL 58 body mass   (VT:0001259)    

Additional Information